Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A VanderMolen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of the National Cancer Institute|March 17, 1993
Primary lymphoma of the kidney: complete remission after systemic chemotherapyL A Vandermolen, R O Dillman
Journal of the National Cancer Institute|September 7, 1988
Lactic acidosis in lymphoma: prompt resolution of acidosis with therapy directed at the lymphomaL A VanderMolen, S Swain, D L Longo
Archives of Internal Medicine|April 1, 1985
Multiple myeloma in a homosexual man with chronic lymphadenopathyL A Vandermolen, K M Fehir, L Rice
American Heart Journal|July 1, 1986
Torsade de pointes: an unusual manifestation of chloral hydrate poisoningJ B Young, L A Vandermolen, C M Pratt
The Western Journal of Medicine|February 1, 1996
Malignant melanoma and pregnancy ten questionsR O Dillman, L A Vandermolen, N M Barth, et al.
American Journal of Hematology|May 1, 1990
Surface light chain phenotype in indolent lymphomas: lack of prognostic significanceL A VanderMolen, P L Duffey, J Cossman, et al.
Blood|November 1, 1989
Diffuse osteosclerosis in hairy cell leukemiaL A VanderMolen, W J Urba, D L Longo, et al.
Annals of Internal Medicine|July 15, 1989
Adrenal insufficiency and interleukin-2 therapyL A VanderMolen, J W Smith, D L Longo, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic melanoma: a phase II trial of the Cancer Biotherapy Research Group (formerly the National Biotherapy Study Group)R O Dillman, M C Wiemann, L A VanderMolen, et al.
Cancer Biotherapy|January 1, 1995
The integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer centerR O Dillman, N M Barth, K Mahdavi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|March 17, 1993
Primary lymphoma of the kidney: complete remission after systemic chemotherapyL A Vandermolen, R O Dillman
Journal of the National Cancer Institute|September 7, 1988
Lactic acidosis in lymphoma: prompt resolution of acidosis with therapy directed at the lymphomaL A VanderMolen, S Swain, D L Longo
Archives of Internal Medicine|April 1, 1985
Multiple myeloma in a homosexual man with chronic lymphadenopathyL A Vandermolen, K M Fehir, L Rice
American Heart Journal|July 1, 1986
Torsade de pointes: an unusual manifestation of chloral hydrate poisoningJ B Young, L A Vandermolen, C M Pratt
The Western Journal of Medicine|February 1, 1996
Malignant melanoma and pregnancy ten questionsR O Dillman, L A Vandermolen, N M Barth, et al.
American Journal of Hematology|May 1, 1990
Surface light chain phenotype in indolent lymphomas: lack of prognostic significanceL A VanderMolen, P L Duffey, J Cossman, et al.
Blood|November 1, 1989
Diffuse osteosclerosis in hairy cell leukemiaL A VanderMolen, W J Urba, D L Longo, et al.
Annals of Internal Medicine|July 15, 1989
Adrenal insufficiency and interleukin-2 therapyL A VanderMolen, J W Smith, D L Longo, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic melanoma: a phase II trial of the Cancer Biotherapy Research Group (formerly the National Biotherapy Study Group)R O Dillman, M C Wiemann, L A VanderMolen, et al.
Cancer Biotherapy|January 1, 1995
The integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer centerR O Dillman, N M Barth, K Mahdavi, et al.
Pageof 2